N-SUBSTITUTED-1H-INDOL-5-PROPIONIC ACID COMPOUNDS AS PPAR AGONISTS USEFUL FOR THE TREATMENT OF DIABETES
申请人:F. Hoffmann-La Roche AG
公开号:EP1539746A1
公开(公告)日:2005-06-15
US6890947B2
申请人:——
公开号:US6890947B2
公开(公告)日:2005-05-10
[EN] N-SUBSTITUTED-1H-INDOL-5-PROPIONIC ACID COMPOUNDS AS PPAR AGONISTS USEFUL FOR THE TREATMENT OF DIABETES<br/>[FR] COMPOSES D'ACIDE 1H-INDOL-5-PROPIONIQUE A SUBSTITUTION N EN TANT QU'AGONISTES DE PPAR UTILES DANS LE TRAITEMENT DU DIABETE
申请人:HOFFMANN LA ROCHE
公开号:WO2004024726A1
公开(公告)日:2004-03-25
Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R8, A, A1 and n have the significance given in claim 1 can be used in the form of pharmaceutical preparations.
Indolyl derivatives
申请人:——
公开号:US20040053979A1
公开(公告)日:2004-03-18
Compounds of formula I are provided
1
as well as pharmaceutically acceptable salts and esters thereof, wherein R
1
to R
8
, A, A
1
and n have the significance indicated in the specification.